Xeltis’ aXess EU key trial shows sustained patency, fewer interventions, [...]
A new survey has found that medical device companies are [...]
In the midst of an opioid crisis and growing frustration [...]
Xeltis’ aXess EU key trial shows sustained patency, fewer interventions, [...]
A new survey has found that medical device companies are [...]
In the midst of an opioid crisis and growing frustration [...]